Clinical Trial Update: Efficacy and Safety of the Combination Vitamin D With Standard of Care in Egyptian Patients With Untreated Chronic Hepatitis C [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating adding Vitamin D to standard of care for untreated Chronic Hepatitis C in Egyptian patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Chronic Hepatitis C | Phase 3 | Status: WITHDRAWN